Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Age-Related Eye Disease Study 2 (AREDS2)

ClinicalTrials.gov ID: NCT00345176

Public ClinicalTrials.gov record NCT00345176. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 10:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Age-Related Eye Disease Study 2 (AREDS2): A Multi-center, Randomized Trial of Lutein, Zeaxanthin and Omega-3 Long-Chain Polyunsaturated Fatty Acids (Docosahexaenoic Acid [DHA] and Eicosapentaenoic Acid [EPA]) in Age-Related Macular Degeneration

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Oral supplementation with the Age-Related Eye Disease Study (AREDS) formulation (antioxidant vitamins C and E, beta carotene, and zinc) has been shown to reduce the risk of progression to advanced age-related macular degeneration (AMD). Observational data suggest that increased dietary intake of lutein + zeaxanthin (carotenoids), omega-3 long-chain polyunsaturated fatty acids (docosahexaenoic acid \[DHA\] + eicosapentaenoic acid \[EPA\]), or both might further reduce this risk. AREDS2 was designed to test whether adding lutein + zeaxanthin, DHA + EPA, or lutein + zeaxanthin and DHA + EPA to the AREDS formulation might further reduce the risk of progression to advanced AMD. A secondary goal was to test the effects of eliminating beta carotene and reducing zinc dose in the AREDS formulation.

Study identification

NCT ID
NCT00345176
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
4,203 participants

Conditions and interventions

Interventions

Dietary Supplement · Drug

Eligibility (public fields only)

Age range
50 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2006 (Type not available)
Primary completion
Oct 2012 (Actual)
Completion
Oct 2012 (Actual)
Last update posted
May 5, 2015

2006 – 2012

United States locations

U.S. sites
91
U.S. states
30
U.S. cities
75
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
Jones Eye Institute - UAMS Little Rock Arkansas 72205 —
Retina-Vitreous Associates Medical Group Beverly Hills California 90211 —
Shiley Eye Center - UCSD La Jolla California 92093 —
Loma Linda University Loma Linda California 92354 —
Doheny Eye Institute Los Angeles California 90033 —
Jules Stein Eye Institute Los Angeles California 90095 —
VA Northern California Health Care System Martinez California 94553 —
Southern California Desert Retina Consultants, MC Palm Springs California 92262 —
University of California, Davis Sacramento California 95817 —
West Coast Retina Medical Group, Inc San Francisco California 94107 —
Pacific Eye Associates San Francisco California 94115 —
Colorado Retina Associates Denver Colorado 80218 —
Eldorado Retina Associates, PC Louisville Colorado 80027 —
Yale University Eye Center New Haven Connecticut 06510 —
Retina Group of Florida Fort Lauderdale Florida 33334 —
University of Florida Jacksonville Florida 32209 —
Bascom Palmer Eye Institute Miami Florida 33136 —
Sarasota Retina Institute Sarasota Florida 34239 —
Center for Retina and Macular Disease Winter Haven Florida 33880 —
Emory University Eye Center Atlanta Georgia 30322 —
Georgia Retina, PC Decatur Georgia 30030 —
Northwestern University Chicago Illinois 60611 —
The University of Illinois Chicago Illinois 60612 —
NorthShore University HealthSystems Glenview Illinois 60026 —
Ingalls Memorial Hospital Harvey Illinois 60426 —
University of Iowa Iowa City Iowa 52242 —
Retina Associates of Kentucky Lexington Kentucky 40509 —
Paducah Retinal Center Paducah Kentucky 42001 —
Elman Retina Group Baltimore Maryland 21237 —
Wilmer Eye Institute, Johns Hopkins Hospital Baltimore Maryland 21287 —
National Eye Institute Bethesda Maryland 20892 —
The Retina Group of Washington Chevy Chase Maryland 20815 —
Massachusetts Eye and Ear Infirmary Boston Massachusetts 02114 —
Ophthalmic Consultants of Boston Boston Massachusetts 02114 —
Kresge Eye Institute Detroit Michigan 48201 —
Henry Ford Health System - Eye Care Services Detroit Michigan 48202 —
Vision Research Foundation Grand Rapids Michigan 49546 —
Vision Research Foundation Royal Oak Michigan 48073 —
Vision Research Foundation Traverse City Michigan 49686 —
Mayo Clinic Rochester Minnesota 55905 —
University Health Care - Mason Eye Institute Columbia Missouri 65212 —
Eye Foundation of Kansas City Kansas City Missouri 64108 —
Mid-America Retina Consultants, PA Kansas City Missouri 64111 —
The Retina Institute St Louis Missouri 63110 —
Washington University School of Medicine St Louis Missouri 63110 —
Delaware Valley Retina Associates Lawrenceville New Jersey 08648 —
UMDNJ Newark New Jersey 07103 —
Ophthalmic Consultants of Long Island Lynbrook New York 11563 —
New York Eye and Ear Infirmary New York New York 10003 —
Manhattan Eye, Ear and Throat Hospital New York New York 10021 —
University of Rochester Eye Institute Rochester New York 14642 —
Retina Consultants, PLLC Slingerlands New York 12159 —
The Research Foundation of SUNY/Stony Brook Stony Brook New York 11794 —
Western Carolina Retinal Associates Asheville North Carolina 28803 —
UNC Department of Ophthalmology Chapel Hill North Carolina 27599 —
Charlotte Eye Ear Nose and Throat Associates Charlotte North Carolina 28210 —
Duke University Durham North Carolina 27710 —
Wake Forest University Eye Center Winston-Salem North Carolina 27157 —
Case Western Reserve University Cleveland Ohio 44106 —
Retina Associates of Cleveland Cleveland Ohio 44122 —
Ohio State University Columbus Ohio 43210 —
Retina Associates of Cleveland Middleburg Heights Ohio 44130 —
Retina Associates of Cleveland Youngstown Ohio 44505 —
Dean McGee Eye Institute Oklahoma City Oklahoma 73104 —
Devers Eye Institute Portland Oregon 97210 —
Retina Northwest, PC Portland Oregon 97210 —
Pennsylvania Retina Specialists, PC Camp Hill Pennsylvania 17011 —
Penn State M.S. Hershey Medical Center Hershey Pennsylvania 17033 —
Scheie Eye Institute Philadelphia Pennsylvania 19104 —
Wills Eye Hospital/Mid Atlantic Retina Philadelphia Pennsylvania 19107 —
Retina Vitreous Consultants Pittsburgh Pennsylvania 15213 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Palmetto Retina Center Columbia South Carolina 29204 —
Carolina Retina Center Columbia South Carolina 29223 —
Southeastern Retina Associates, PC Knoxville Tennessee 37909 —
University of Tennessee Memphis Tennessee 38163 —
Vanderbilt Eye Institute Nashville Tennessee 37232 —
Texas Retina Associates Arlington Texas 76012 —
Texas Retina Associates Dallas Texas 75231 —
UT Southwestern Medical Center Dallas Texas 75390 —
Baylor College of Medicine Houston Texas 77030 —
Retina Consultants of Houston Houston Texas 77030 —
Texas Retina Associates Lubbock Texas 79424 —
Scott and White Memorial Hospital Temple Texas 76508 —
John Moran Eye Center Salt Lake City Utah 84132 —
Fletcher Allen Health Care Burlington Vermont 05401 —
The Retina Group of Washington Fairfax Virginia 22031 —
Retina Center Northwest Silverdale Washington 98383 —
University of Wisconsin Madison Wisconsin 53705 —
The Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00345176, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2015 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00345176 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →